Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 230, Issue 1
Volume 230, Issue 1
15 July 2024
ISSN 0022-1899
EISSN 1537-6613

Volume 230, Issue 1, 15 July 2024

Editorial Commentary

Cynthia L Sears
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Page 1, https://doi.org/10.1093/infdis/jiae326

Perspective

Brendan J Kelly and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 2–4, https://doi.org/10.1093/infdis/jiae099

FDA approval of the first microbiota therapeutics raises new questions about the future role of fecal microbiota transplantation (FMT). The authors explore these questions and suggest that FMT has unique value for research and to support patient access.

Major Articles and Brief Reports

COVID-2019 Disease Pathogenesis

Jiajia Lin and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 5–14, https://doi.org/10.1093/infdis/jiae048

Cytotoxic lymphocytes attach to CD14+ monocytes with high inflammasome assembly capability and elevated antigen-presenting potential in COVID-19 progression and convalescent stages, representing a dynamic systemic immune response upon SARS-CoV-2 infection.

Elise A Chong and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 15–27, https://doi.org/10.1093/infdis/jiae106

Individuals with lymphoma were at risk for reduced or absent vaccine response, even when untreated. Normal circulating immunoglobulins increased the likelihood of response. CART-19 did not permanently impair response, with the presence of Tfh and B cells predicting receptor-binding domain–specific IgG.

Xingyu Zheng and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 28–37, https://doi.org/10.1093/infdis/jiae061

In this study, we demonstrated that Treg cells and CXCR3+ cTfh cells concordantly shape the nAb responses in people who have recovered from mild but not severe COVID-19. Treg cells limit the nAb responses by limiting CXCR3+ cTfh cells function.

Peter Harteloh and Rob van Mechelen
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 38–44, https://doi.org/10.1093/infdis/jiae071

The coronavirus disease 2019 (COVID-19) pandemic has been called the deadliest disease event in history. However, in the Netherlands, a comparison accounting for population differences shows that the Spanish flu of 1918–1920 was deadlier than COVID-19 in 2020–2022.

Kelsey M Sumner and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 45–54, https://doi.org/10.1093/infdis/jiae090

From October 2021 to June 2022, we assessed the association between antibody concentration and COVID-19 illness among patients enrolled in a test-negative study in 7 US states. We found that higher anti–receptor-binding domain antibodies in patients were associated with protection against symptomatic COVID-19.

HIV/AIDS

Jean-Damien Combes and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 55–60, https://doi.org/10.1093/infdis/jiad506

Among 410 men having sex with men living with human immunodeficiency virus and undergoing annual anal cytology and high-resolution anoscopy, 33% had high-grade anal lesions detected within 2 years; strongest determinants were baseline positivity for human papillomavirus 16 and p16/Ki67.

Xiaolei Wang and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 61–66, https://doi.org/10.1093/infdis/jiae058

Predicting abnormal cervical cytology based on vaginal microecological disorders helps clinicians in the early identification of women with HIV, who are at a higher risk of cervical cancer, and this might be a primary prevention strategy.

Christopher S Wilcox and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 67–77, https://doi.org/10.1093/infdis/jiae094

Perivascular adipose tissue surrounding small subcutaneous vessels from women with HIV has oxidative stress, inflammation, and reduced adiponectin that may contribute to enhanced contractility and microvascular disease.

Jeffrey A Johnson and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 78–85, https://doi.org/10.1093/infdis/jiae073

Under potent INSTI-based therapy, HIV was observed to maintain residual expression below the detection of standard clinical testing, uncovering nonlymphoid-derived viruses in the male genital tract that were highly divergent and distinct from lymphoid-derived variants present in blood.

Rachel M Burdorf and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 86–94, https://doi.org/10.1093/infdis/jiae131

Carrying the drug resistance mutation K103N at either low or high frequency when starting a nonnucleoside reverse transcriptase inhibitor antiretroviral therapy regimen increases treatment failure risk.

Viral Disease Pathogenesis

Ang Wei and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 95–102, https://doi.org/10.1093/infdis/jiad435

Different subtypes in chronic active Epstein-Barr virus infection demonstrated specific clinical features. Generally, patients with CD8+ T-cell type had a poor prognosis.

Soyeoun Kim and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 103–108, https://doi.org/10.1093/infdis/jiad437

This study aimed to determine if emergency department (ED) data could reflect norovirus trends. A significant correlation was found between reported cases, especially in children, and specific ED visit complaints. ED data can help detect infectious disease trends early.

Yumiko Hashida and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 109–119, https://doi.org/10.1093/infdis/jiad521

This study reports preferential detection of high levels of cutavirus DNA with the expression of viral mRNA in large-plaque parapsoriasis. This suggests a potential role for cutavirus in the pathogenesis of the disorder, a premalignant condition of mycosis fungoides.

Carola Ledderose and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 120–130, https://doi.org/10.1093/infdis/jiad442

Influenza infection releases adenosine triphosphate that primes peripheral neutrophils and causes their excessive activation after they infiltrate the lungs. Thus, adenosine triphosphate–induced neutrophil priming may be a therapeutic target to reduce lung tissue damage in severe influenza cases.

Kyueun Lee and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 131–140, https://doi.org/10.1093/infdis/jiad541

With expedited vaccine production, reconsidering existing timelines for seasonal influenza vaccine selection could result in substantial epidemiological advantages, especially when additional data could enhance the antigenic alignment between vaccine and prevalent viruses.

Mark W Tenforde and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 141–151, https://doi.org/10.1093/infdis/jiad542

Among US adults, including older adults and persons with high-risk medical conditions, influenza vaccination provided moderate protection against influenza A–associated emergency department or urgent care encounters (vaccine effectiveness [VE], 44%) and hospitalizations (VE, 35%) during the 2022–2023 influenza season.

Global Health

Wey Wen Lim and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 152–160, https://doi.org/10.1093/infdis/jiae122

Hemagglutination inhibition antibody titers mediate 20%–40% of inactivated influenza vaccine efficacy against influenza A(H1N1), A(H3N2), and B/Victoria virus infections.

Alba Marín-Moreno and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 161–171, https://doi.org/10.1093/infdis/jiae093

Humanized mice exposed to a panel of animal atypical scrapie prions showed very low susceptibility, suggesting a limited zoonotic potential. However, 1 isolate adapted into prions phenotypically resembling those causing human sporadic Creutzfeldt-Jakob disease. Further characterization dismissed a causal link.

Parasites

Shalini Roy and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 172–182, https://doi.org/10.1093/infdis/jiae158

Developing novel therapeutics for visceral leishmaniasis is a pressing need. We demonstrated that the antimicrobial peptide cathelicidin, administered externally, has an antileishmanial effect. However, infection downregulates endogenous cathelicidin by exploiting host protein CREM, which could be a potential drug target.

Rik Hendrickx and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 183–187, https://doi.org/10.1093/infdis/jiae219

Comprehensive in vitro and in vivo experiments and analyses in patients with visceral leishmaniasis identify spliced-leader RNA (SL-RNA) as a parasite viability marker. An optimized protocol allows the versatile detection of SL-RNA and other molecular markers for individualized patient management.

Bacterial Disease Pathogenesis

Supeng Yin and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 188–197, https://doi.org/10.1093/infdis/jiad454

This study revealed that SspA-1 of the highly virulent Streptococcus suis 2 strain induces an excessive inflammatory response via TLR2 endosomal and type I IFN signaling, unveiling a novel role of type I IFN in S. suis infection.

Femke D Hollwedel and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 198–208, https://doi.org/10.1093/infdis/jiad608

This study characterized the 2 glycolipids of Staphylococcus aureus, Glc-DAG and Glc2-DAG, acting as molecular patterns with opposing activities in Mincle-dependent lung anti-staphylococcal immunity in mice.

William Bain and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 209–220, https://doi.org/10.1093/infdis/jiae003

Disruption of the capsule biosynthesis gene wcaJ evolved in a patient with recurrent Klebsiella pneumoniae carbapenemase–producing K pneumoniae bloodstream infections. Loss of function in wcaJ led to resistance to complement-mediated killing as well as increased complement binding and osponophagocytosis.

Dongmei Xu and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 221–230, https://doi.org/10.1093/infdis/jiae008

Patients with neurosyphilis at different stages have distinctive patterns of soluble factors in the cerebrospinal fluid (CSF), which are correlated with immune status and neuronal damage. Moreover, CSF biomarker panels were identified that may accurately discriminate neurosyphilis at different stages.

Genomes & Microbiome

Jianguo Huang and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 231–238, https://doi.org/10.1093/infdis/jiae044

Twelve novel ccr genes were identified in staphylococci and mammaliicocci, forming 12 novel ccr gene complexes and 10 novel SCC elements. The biological activity of 5 groups of novel Ccr recombinases were further demonstrated.

Allison K Guitor and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 239–249, https://doi.org/10.1093/infdis/jiae049

This study compared azithromycin treatment for bacterial diarrhea in children in Botswana to the usual care to evaluate its impact on antibiotic resistance in the gut microbiome. In both treatment groups, azithromycin resistance genes increased in prevalence at 60 days.

Review

Mary Bridget Waters and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 250–262, https://doi.org/10.1093/infdis/jiae199

This narrative review summarizes the “state of the science” for Chlamydia trachomatis seroassays that have been applied in epidemiologic studies and provides practical considerations for interpreting the literature and employing seroassays in future research.

Tiffany Fang and Choukri Ben Mamoun
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 263–270, https://doi.org/10.1093/infdis/jiae191

This review focuses on the B. duncani ICIM model, which serves as a promising resource for advancing research into the biology, pathogenicity, and virulence of intraerythrocytic parasites, as well as a tool to evaluate new drugs, vaccines, and diagnostic tests.

Correspondence

Geoffrey S Dow and Bryan Smith
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 271–272, https://doi.org/10.1093/infdis/jiae193
Choukri Ben Mamoun and Gary P Wormser
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Page 273, https://doi.org/10.1093/infdis/jiae194

Online-Only Articles

Perspectives

Jessica Swenson and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e1–e3, https://doi.org/10.1093/infdis/jiae017

Synergies between funders within the medical countermeasure life cycle are critical to ensure long-term sustainment and availability of vaccines, therapeutics, and diagnostics.

Major Articles and Brief Reports

COVID-2019 Disease Pathogenesis

Chijioke Bennett and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e4–e16, https://doi.org/10.1093/infdis/jiad508

The Omicron BA.1 variant–specific vaccine NVX-CoV2515 elicited a superior neutralizing antibody response against the Omicron BA.1 subvariant as compared with the prototype vaccine, NVX-CoV2373, when administered as a fourth dose. Safety data were consistent with the established safety profile of NVX-CoV2373.

Jasmin K Sidhu and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e17–e29, https://doi.org/10.1093/infdis/jiad590

Fatal COVID-19 is associated robust peripheral inflammation; however, early interferon-led responses in the respiratory mucosa are delayed relative to those that will survive severe SARS-CoV-2 infection.

Zahra R Tehrani and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e30–e33, https://doi.org/10.1093/infdis/jiad603

By studying the bone marrow aspiration samples of 20 individuals with prior coronavirus disease 2019, we showed deficient generation of spike-specific long-lived plasma cells in bone marrow as the major contributor to the nondurable humoral immune response to this infection.

HIV/AIDS

Emilie R Elliot and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e34–e42, https://doi.org/10.1093/infdis/jiad580

CAB + RPV LA is effective in the maintenance of HIV-1 virologic suppression in adults regardless of BMI category, with longer-length needles (≥2 inches) recommend for those with BMI ≥30 kg/m2 to accommodate individual body habitus and ensure appropriate administration.

Nienke H van Teijlingen and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e43–e47, https://doi.org/10.1093/infdis/jiae166

Exposure to Prevotella timonensis, a bacterium associated with vaginal dysbiosis, increased uptake, fusion, and production of HIV-1 by vaginal CD4+ T cells, thereby enhancing HIV-1 susceptibility. Pre-exposure of CD4+ T cells to antiretroviral inhibitors abolished P timonensis–enhanced HIV-1 infection.

Lara I Allen and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e48–e59, https://doi.org/10.1093/infdis/jiae206

Viral Disease Pathogenesis

Cornelia A M van de Weg and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e60–e64, https://doi.org/10.1093/infdis/jiad389

Markers of endothelial cell activation were measured in patients with yellow fever virus infection at the time of presentation. Extremely increased levels of angiopoietin 2 were detected in nonsurvivors vs survivors, suggesting that angiopoietin 2 could serve as a predictive marker for mortality.

Stephanie A Kujawski and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e65–e74, https://doi.org/10.1093/infdis/jiad420

This study highlights high antibiotic use and healthcare resource utilization associated with varicella management, particularly in patients with complications. A national varicella vaccination program in England may reduce varicella burden and related complications, medication use, and costs.

Jenna Ciszewski and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e75–e79, https://doi.org/10.1093/infdis/jiad502

We estimated the effect of rotavirus vaccination on duration and quantity of rotavirus shed during rotavirus gastroenteritis in Bangladesh. Virus quantity was lower in symptomatic vaccinated children compared to symptomatic unvaccinated children, but differences in episode duration were small.

Deshayne B Fell and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e80–e92, https://doi.org/10.1093/infdis/jiad539

Influenza vaccination during pregnancy was protective against influenza infection and influenza hospitalization among infants <6 months of age. Because influenza vaccines are not available for this age group, vaccination during pregnancy can offer passive protection to young infants.

Jonne Terstappen and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e93–e101, https://doi.org/10.1093/infdis/jiad543

Neutralizing antibodies against respiratory syncytial virus in serum and dried blood are highly correlated, are stable in dried blood for 6 months, and can withstand temperature variation. Dried blood samples are a patient-centered and logistical solution for clinical trials.

Tino F Schwarz and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e102–e110, https://doi.org/10.1093/infdis/jiad546

One dose of prefusion F protein–based vaccine for older adults administered to ≥60-year-olds induced humoral and cell-mediated immune responses that remained above pre–dose 1 levels for at least 1 year. The vaccine was well tolerated with an acceptable safety profile.

Thomas C Williams and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e111–e120, https://doi.org/10.1093/infdis/jiad551

The BronchStart study collected data on 17 899 presentations in children aged <2 years with serious respiratory disease following the lifting of lockdown measures. For infant admissions, 51.3% were not associated with RSV; the majority were in previously healthy term infants.

Global Health

Maria Xiridou and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e121–e130, https://doi.org/10.1093/infdis/jiad414

Modelling study shows that the decline in mpox cases among MSM in the Netherlands was primarily due to infection-induced immunity among those with high sexual activity levels and accelerated by behavioral adaptions. The outbreak could have faded even without vaccination.

Anne Eudes Jean Baptiste and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e131–e138, https://doi.org/10.1093/infdis/jiad476

Nigeria has the highest number of children missing out on all routine immunization vaccinations—“zero-dose children.” Geospatial models can predict areas with zero-dose and underimmunized children for targeted interventions to achieve the Immunization Agenda 2030 goals.

Rebecca A Clark and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e139–e143, https://doi.org/10.1093/infdis/jiae089

Adolescent/adult targeted BCG revaccination assumed to prevent sustained Mycobacterium tuberculosis infection may have a positive health impact and be cost-effective in India and South Africa, even if associated with up to 50% increased risk of progression to disease.

Parasites

Matthew A Knox and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e144–e148, https://doi.org/10.1093/infdis/jiae065

DNA repeat regions differentiate subtypes and track Cryptosporidium outbreaks but have high replication slippage rates. Using synthesized DNA, we demonstrate that slippage rates increase with the length of repeat region and can contribute to error rates of up to 20%.

Bacterial Disease Pathogenesis

Samantha A Henry and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e149–e158, https://doi.org/10.1093/infdis/jiad540

Computational and microbiological techniques were used to identify the steroid drug quinestrol as an inhibitor of cytochrome bd respiratory complexes from Escherichia coli and Staphylococcus aureus. This drug was bacteriostatic toward both species but was only lethal toward S. aureus.

Yu Wan and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e159–e170, https://doi.org/10.1093/infdis/jiae019
Matthew M Munch and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e171–e181, https://doi.org/10.1093/infdis/jiae026

Prevalence and concentrations of 4 Gardnerella species groups as measured by quantitative PCR were significantly associated with bacterial vaginosis (BV). Detection of multiple Gardnerella species was a risk factor for BV development, and none were a specific marker for BV.

Ognjen Sekulovic and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e182–e188, https://doi.org/10.1093/infdis/jiae038

Pneumococcal serotype 3 clinical isolates display variable and clade-dependent biological characteristics in a mouse model of pneumococcal invasive disease and carriage.

Akuzike Kalizang'oma and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e189–e198, https://doi.org/10.1093/infdis/jiae040

A ST700-GPSC10 serotype 3 Streptococcus pneumoniae lineage, currently restricted to the African continent, is characterized by the absence of 6 genes from the capsular polysaccharide locus and decreased susceptibility to opsonophagocytosis, which may explain the spread of this lineage.

Review

Emily K Horn and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages e199–e218, https://doi.org/10.1093/infdis/jiae087

Ongoing hepatitis A outbreaks in the United States are associated with a substantial clinical and economic burden. Prevention strategies and efforts to increase awareness and vaccination coverage are needed to reduce the burden of hepatitis A and prevent future outbreaks.

Corrections

The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Page e219, https://doi.org/10.1093/infdis/jiae186
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Page e220, https://doi.org/10.1093/infdis/jiae121
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close